MARCH 2018 SURETY MEDICINE TELECONFERENCE
March 2018 will bring the next Surety Medicine Teleconference, at 1 pm (1300 hrs) Eastern Time. The topic for March is "Updates in the Diagnosis and Treatment of Nerve and Vesicant Agent Exposures.” The presenter will be a physician board certified in Internal and Pulmonary Medicine with specialized expertise in toxic inhalational exposures, and with extensive experience in planning chemical warfare agent medical response in the U.S. and internationally.
To request additional information, email the Army Public Health Center Surety Medicine Division at:
SCHEDULE OF SURETY MEDICINE TELECONFERENCES FOR FY 2018
|21 MAR 2018||Updates in the Diagnosis and Treatment of Nerve & Vesicant Agent Exposures|
| 18 APR 2018 || Hearing Conservation and Audiometric Testing in Surety Programs |
| 16 MAY 2018 || HIV: CD4 Counts, Antiretroviral Drugs, and Impaired Immune Functions in PRP |
| 27 JUN 2018 || Diagnosis, Evaluation and Screening of Laboratory-Acquired Alpha Virus Infections |
| 18 JUL 2018 || Screening Diabetics for Reliability and Suitability in the PRP |
| 15 AUG 2018 || Case Studies in Personnel Reliability Program Surety Management |
| 26 SEP 2018 || Animal Worker Occupational Health Issues in the PRP |
Auto-Injector Shelf Life Extension Program:
NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM
Three production lots of atropine nerve agent antidote auto-injectors expired 31 January 2018! In addition, many expiration date extensions for auto-injector medications expired in 2017! Check any auto-injector medication stores you have. Select the link below for additional information.
The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote(R) combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to
2022. Complete FDA information related to the auto-injector shelf life extension program can be found at this FDA Drug Safety Page.
Information on this page also includes the latest updates (6/26/2017) on shelf life extensions for the AtroPen(R) (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors.